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(G. Travé).The canonical binding mode of PDZ domains to target motifs involves a small interface, unlikely to
fully account for PDZ-target interaction speciﬁcities. Here, we review recent work on sequence con-
text, deﬁned as the regions surrounding not only the PDZ domains but also their target motifs. We
also address the theoretical problem of deﬁning the core of PDZ domains and the practical issue of
designing PDZ constructs. Sequence context is found to introduce structural diversity, to impact the
stability and solubility of constructs, and to deeply inﬂuence binding afﬁnity and speciﬁcity, thereby
increasing the difﬁculty of predicting PDZ-motif interactions. We expect that sequence context will
have similar importance for other protein interactions mediated by globular domains binding to
short linear motifs.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Interactions between proteins are essential for most of the pro-
cesses that happen in living cells. Many protein interactions in cell
signalling are mediated by interactions between globular domains
and short linear motifs (SLiMs) [1]. SLiMs are short disordered pro-
tein sequence segments that often become folded in their bound
state [1,2]. Important insights on domain–SLiM interactions have
been gained from studies on PDZ (PSD95-DLG1-ZO1) domains.
PDZ domains constitute a large family of globular domains found
in prokaryotes and eukaryotes [3] with about 270 occurrences in
the human proteome (see next section). PDZ-domain containing
proteins are implicated in diverse cellular functions such as estab-
lishment and maintenance of cell polarity [4], signal transmission
in neurons [5] or in visual and auditive processes in the eye and
ear [6,7], cell migration [8], and regulation of cell junctions [9]
(for reviews see [10,11]).
The core PDZ fold adopts an antiparallel b barrel structure [12]
comprising 5–6 b strands and 1–2 a helices (Fig. 1A). PDZ domains
mainly recognize PDZ-binding motifs (PBMs) that are situated atal Societies. Published by Elsevier
uck), gilles.trave@unistra.frthe very C-terminus of proteins. Some PDZ domains may also bind
internal (i.e. non-C-terminal) PBMs [13,14] or lipids [15]. PBMs
bind via b augmentation to PDZ domains, e.g. PBMs adopt a b
strand that pairs in an antiparallel manner with the b2 strand of
the PDZ domain (Fig. 1A). The carboxylate group of the last residue
of the SLiM (here, the term peptide will be equally used) is hydro-
gen-bonded to backbone amides of residues from the carboxylate
binding loop (b1–b2 loop), thereby determining the C-terminal
peptide selectivity of PDZ domains (Fig. 1A). Based on the recogni-
tion of C-terminal SLiMs, peptide positions are numbered starting
from the last residue (position 0, p0) going backwards (p1, p2,
and so forth). The last residue is almost always a hydrophobic res-
idue, mainly Val, Leu or Ile. The third last peptide residue (p2) can
be either Thr or Ser (class I), hydrophobic (class II), or Glu or Asp
(class III), thereby deﬁning three main categories of PDZ-binding
motifs [16,17]. Thus, recognition of SLiMs by PDZ domains is based
on residues of two key peptide positions, p0 and p2.
Indeed, it has been generally observed that SLiMs have on aver-
age less than four deﬁned positions [2]. Given this small binding
interface, numerous studies addressed the question about how
SLiMs can fulﬁll the need for speciﬁc protein interactions in cell
signalling [18–22]. An increasing number of studies now suggests
that protein interactions in cell signalling are not only determined











































Fig. 1. Available structural information on PDZ domains. (A) Structure of the PDZ
domain of AF6 (Afadin) bound to a C-terminal peptide (LFSTEV) derived from Bcr
(PDB ID: 2AIN [112]). The secondary structure elements, peptide positions, and the
common signature of the carboxylate binding loop (G/G/ where / represents a
hydrophobic residue) are indicated. Green dashed lines represent hydrogen bonds
that are established between Val at p0 and the carboxylate binding loop. Figure was
created with Pymol [113]. (B) Diagram that illustrates the number of human PDZ
domains for which there is at least a structure of a PDZ domain in the PDB with X %
sequence similarity based on local sequence alignments from BLAST searches (e.g.
for 152 human PDZs there is a structure of a PDZ in the PDB with at least 80%
sequence similarity.)
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either encoded within the sequences of the two interacting pro-
teins; or deﬁned by the cellular environment. In our deﬁnition, cel-
lular context comprises factors that inﬂuence the temporal and
spacial distribution of proteins, thereby determining when and un-
der which conditions (e.g. local concentration) two proteins will
meet in order to bind each other [25]. Sequence context comprises
the regions in proteins that surround SLiMs or globular domains
and that were shown to have an impact on the domain–SLiM inter-
actions. Here, we refer to sequence context as extensions, if they oc-
cur directly upstream or downstream of the SLiM or domain and if
they are not part of other domains. Sequence context that is not
considered as extensions consists of neighbouring domains and re-
gions that are not in the neighbourhood of the SLiM or domain.
The repertoire of structures on PDZ domains deposited in the
Protein Data Bank (PDB) [27] is immense (Fig. 1B) providing us
with a unique perspective on the structural diversity that exists
within one protein domain family. Given the accumulated knowl-
edge about PDZ–peptide interactions, they can serve as a model
system to understand how domain–SLiM interactions are inﬂu-
enced by their sequence context. In the following, we will review
studies that provide insights on extensions of PBMs and PDZs as
well as studies that investigated the interplay between PDZ do-
mains and their neighbouring domains.
2. Precision of the total number of PDZ domains in the human
proteome
There has been considerable confusion about the total number
of PDZ domains in the human proteome (hereafter called human
PDZome). Numbers that are frequently referred to in the ‘‘PDZ liter-
ature’’ range from about 250 up to 900. Based on the articles that
justify the number of human PDZs claimed in their text, we identi-
ﬁed three different sources. Articles that claim a total number of
450 human PDZ domains (see suppl. data for references), refer to
the database SMART [28]. Indeed, SMART provides a list of the hu-man PDZome. However, upon closer inspection, this list turned out
to be highly redundant, probably because it has been based on a set
of protein sequences containing several isoforms for the same gene
that have identical PDZ sequences. By now, SMART decreased the
original number from 450 down to 364 (as of February 2012). Spal-
ler [29] represents the second source, which claimed a total number
of 918 human PDZ domains. In an erratum published four years la-
ter, Spaller corrected this number down to 234 and explained that
he had been misled by erroneous numbers that were present in the
preprint (but not the ﬁnal version) of Bhattacharyya et al. [30].
Nonetheless, articles are still being published that seem to ignore
the erratum [31]. Finally, several independent studies [32–34] that
aimed at ﬁnding all human PDZ domains for bioinformatic analyses
converge on a total number of about 270 PDZs in the human prote-
ome without counting alternatively spliced forms of PDZs. This lat-
ter number, which we conﬁrmed in our own investigations, is most
probably the best estimate of the size of the human PDZome.3. Extensions of PBMs
In numerous low-scale and large-scale studies as well as bio-
computational analyses researchers sought to decipher the speci-
ﬁcity rules of PDZ–peptide interactions [19,35–38]. Apart from
peptide residues at p0 and p2, which are the hallmarks for recog-
nition by PDZs, the role of other residues of the PBM is more vari-
able. Some studies suggested that the contribution of residues at
p1 and p3 to the overall binding event is minor whereas in
other studies PDZ domains exhibited clear preferences for certain
residues at these sites over others [39–43]. More and more studies
now converge on the idea that PBMs should at least be extended to
p4 as residues at this position have also been observed to signif-
icantly contribute to the binding to PDZs [19,35]. By extending the
PBM further and further, a few interesting studies indicate that
peptide residues up to p10 are also implicated in PDZ binding.
In the following, we deﬁne the core PBM as consisting of the last
four residues (these residues clearly bind in the binding pocket
of PDZ domains between the b2 strand and the a2 helix) and any
longer PBMs will be considered as being extended.
3.1. Residues upstream of the core PBM modulate the binding afﬁnity
to PDZ domains
Interesting observations about PDZ–peptide recognition involv-
ing an extended PBM were obtained when comparing the binding
of peptides derived from Wnt-signalling protein bCatenin and in-
ward rectiﬁer K(+) channel protein Kir2.3 to the PDZ domain of
TIP1 (tax-interacting protein 1). A long bCatenin peptide bound
stronger than a short peptide to the TIP1 PDZ [44,45]. The main
contributor to this difference in afﬁnity is most probably Trp at
peptide position p5 (in the following, we will write W5Þ. Muta-
tion of W5 to Ala signiﬁcantly weakened binding, as did mutation
of Pro to Ala or Ser in the b2–b3 loop of the PDZ domain facing W5
[44]. Interestingly, mutation of R5 to Trp in Kir2.3 peptide led to
an astonishing increase in binding afﬁnity from 6.4 lM to 8.5 nM
[46] (Table 1). As for the TIP1-bCatenin interaction, W5 in the bPix
C-terminus (Rho guanine nucleotide exchange factor 7) contributes
to the binding to PDZ1 of SHANK1 (SH3 and multiple ankyrin re-
peat domains protein 1) as its mutation to Ala reduced binding
afﬁnity, too [47] (Table 1).
3.2. Electrostatic interactions between residues of extended peptides
and of PDZ domains
The charge of the residue at position p5 of the C-terminus of
two inward rectiﬁer K(+) channel proteins GIRK3 and IRK1
Table 1
Mutagenesis performed to study extended PBMs. The table summarizes the mutational data obtained from studies that analysed interactions between residues from extended
PBMs and PDZ domain residues. If available, measured binding afﬁnities are indicated. wt = wild type, Cter = C-terminal extension of PDZ, alt.spl. = alternatively spliced, Nter-
PDZ = construct comprising the PDZ extended at its N-terminus, AA = amino acids, CC = coiled-coil.
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main of SNX27 (sorting nexin 27) or the ﬁrst two PDZ domains of
PSD95 (postsynaptic density protein 95, DLG4). Exchanging Glu atposition p5 of GIRK3 with Arg, as observed in IRK1, was sufﬁcient
to induce the binding of GIRK3 to PSD95 and to disrupt its interac-
tion with SNX27 [48].
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gested ionic contacts between the b2–b3 loop of PDZ3 of DLG4
(disks large homolog 4) and of a C-terminal peptide derived from
CRIPT (cysteine-rich interactor of PDZ3) that seemed to be impor-
tant for peptide binding.
Structural and mutagenesis studies provided evidence for elec-
trostatic interactions between PDZ2 (also referred to as PDZ1) of
MAGI1 (membrane-associated guanylate kinase inverted 1) and
an extended C-terminal peptide derived from Human Papillomavi-
rus (HPV) 16 E6 [50–52]. Mutation of the negative charges in the
b2–b3 loop of PDZ2 to Gln and Asn or Ala signiﬁcantly reduced
the binding afﬁnity as did mutation of the positive charges at posi-
tion -4, -5 and -7 to Ala in the E6 peptide [51] (Table 1). In another
study, the contribution of upstream peptide residues to the binding
afﬁnity to PDZ2 of MAGI1 has been more generally assessed. By
measuring binding afﬁnity of several peptides of different length,
the preference of PDZ2 of MAGI1 for peptides with positive charges
upstream the core PBM has been conﬁrmed [26]. This is one clear
case where an increase in speciﬁcity is driven by interactions be-
tween residues of extended PBMs and residues of the b2–b3 loop.
In contrast, the b2–b3 loop of PDZ3 of MAGI1 did not seem to con-
tribute at all to peptide binding [26]. The same peptides were also
assayed for binding to PDZ3 of the cell polarity protein hScrib
revealing that extended peptides generally bound with higher
afﬁnity to PDZ3. This study demonstrates that depending on the
PDZ in question, interactions between upstream peptide residues
and the b2–b3 loop can have different implications on peptide
binding [26].
3.3. The sequence of the b2–b3 loop inﬂuences peptide binding
C-terminal peptides of APC (adenomatous polyposis coli pro-
tein), the glutamate receptor subunit NR2B, and HPV18 E6 bind
stronger to PDZ2 of DLG1 (disks large homolog 1) as compared
to PDZ1 of the same protein [53–55] (Table 1). Several studies
suggest that amino acid differences in the b2–b3 loop of these
two PDZ domains mainly account for the different binding prefer-
ences via interaction with residues of extended PBMs. Mutation
of a Gln in the b2–b3 loop of PDZ2 to Pro (the corresponding res-
idue in PDZ1) decreased binding afﬁnity for APC [53]. The con-
verse mutation (Pro to Gln) directed at the equivalent position
of the b2–b3 loop of PDZ1 increased binding afﬁnity of PDZ1
for NR2B whereas mutation of the same Pro of PDZ1 to Ala did
not alter the binding afﬁnity [55]. The Pro in the b2–b3 loop of
PDZ1 might also be responsible for weaker binding to E6 in com-
parison to PDZ2. Liu et al. [54] noticed that the neighbouring res-
idues of the Gln in PDZ2 adopt a particular conformation that
contributes to peptide binding, and suggested that the Pro in
PDZ1 did not allow its neighbouring residues to adopt a similar
favorable conformation. One reason for the weaker binding dis-
played by PDZ3 to these peptides might be its shorter b2–b3 loop,
which does not provide such a platform for extended peptide
binding as does PDZ2 [53–55].
3.4. Extended PBMs confer dual binding speciﬁcity to PDZ domains
A few PDZ domains were shown to have dual speciﬁcity, e.g.
binding to PBMs of class I and class II. The dual speciﬁcity of PICK1
(protein interacting with C kinase 1) has been mainly attributed to
speciﬁc residues of the a2 helix [56]. In contrast, the dual speciﬁc-
ity of PDZ3 of the cell polarity protein Par3 can be attributed to an
extended binding pocket [57]. PDZ3 of Par3 binds to long C-termi-
nal peptides derived from both the vascular endothelial Cadherin
(class II PBM, 12 residues) and phosphatase PTEN (class I PBM,
11 residues). However, it signiﬁcantly binds weaker to a shorter(6-residue long) Cadherin peptide and does not detectably bind
anymore to a shorter (8-residue long) PTEN peptide [58,57] (Table
1).
Analysis of the two available NMR structures of these two com-
plexes revealed several contacts between negatively charged resi-
dues in the extended peptides and positively charged residues of
the b2 and b3 strand as well as the b2–b3 loop of PDZ3 [58,57]
(Fig. 2A and B). Whereas the Cadherin peptide mediated more
favourable interactions by means of its last four peptide residues,
the PTEN peptide established more favourable contacts to PDZ3
with its upstream residues. At ﬁrst sight this might be interpreted
as an example where a longer binding pocket leads to more pro-
miscuous binding behaviour. Yet, class I peptides such as PTEN
have to ﬁt very well to the extended binding site with their up-
stream residues in order to be bound by PDZ3, a constraint that
might only be fulﬁlled by a few peptide sequences.
3.5. Conformational changes of the b2–b3 loop upon peptide binding
As indicated by the previous examples, residues from extended
PBMs mainly modulate binding afﬁnity to PDZ domains via inter-
action with residues of the b2–b3 loop. Comparison of available
apo (unbound) and holo (bound) NMR and crystal PDZ structures
revealed that the b2–b3 loop either changes conformation upon
peptide binding or remains unchanged. Two examples of the latter
case are represented by PDZ2 of DLG1 and Erbin (Erbb2-interacting
protein) PDZ of which the b2–b3 loops exist in a stable conforma-
tion when no peptide is bound and this conformation remains un-
changed upon peptide binding, also when complexed to different
peptides. In Erbin PDZ, there is a chain of aliphatic contacts from
the b2–b3 loop to the b3 strand and the b4 strand (Fig. 2C). Addi-
tionally, N1345 of the b2–b3 loop seems to establish a hydrogen
bond to the backbone of the loop. These interactions between res-
idues of the Erbin PDZ are probably the driving forces that keep
that loop very rigid providing a stable platform for peptide binding.
The b2–b3 loop of PDZ1 of ZO1 (Zonula occludens protein 1) is
equally long as that of Erbin PDZ, and it adopts a similar conforma-
tion upon peptide binding, but it displays a different conformation
in its unbound form. Here, the loop seems to restructure upon pep-
tide binding allowing for accommodation of upstream peptide res-
idues (Fig. 2D). Similar observations were obtained for the b2–b3
loop of the TIP1 PDZ domain (Fig. 2E2) and the PDZ of SHANK1
[47].
3.6. The b2–b3 loop can form an additional peptide binding pocket
that accommodates upstream peptide residues
In many of the examples mentioned in the previous subsec-
tions, the b2–b3 loop contributed to the formation of an additional
peptide binding pocket together with residues from strands b2, b3,
and sometimes b4. In particular, an aromatic residue (mainly F or
Y), located right at the beginning of the b3 strand, is often involved
in the formation of this additional pocket. This residue contributed
to the binding of peptide residues upstream position -3 and
seemed to serve as an anchoring point for the structuring of the
b2–b3 loop. The conserved aromatic character of this position in
the family of PDZ domains suggests that residues at this position
might be of more general importance for the structure and func-
tion of PDZs [49].
In general, this additional pocket was frequently observed to
have hydrophobic character being occupied by upstream peptide
residues with large aliphatic side chains such as Trp, Tyr, or Arg
(Erbin PDZ, PDZ1 of ZO1, TIP1 PDZ, Fig. 2C–E1, respectively). How-
ever, in the case of the PDZ of SNX27, this additional pocket is
rather of hydrophilic character being formed by three arginines
Fig. 2. Contacts between residues of extended PBMs and PDZ residues. The table summarizes the contacts that were observed between residues in extensions of PBMs and
residues of PDZ domains or their extensions. A structural representation is provided for most of these PDZ–peptide complexes. Colour code: peptide residues in blue, PDZ
residues from holo NMR structures in orange, from apo NMR structures in dark-green, from holo crystal structures in yellow, and from apo crystal structures in light-green.
Structural information was used from the following PDB entries: (A) 2K20 [58]; (B) 2KOH [57]; (C) 1MFG [61], 1N7T [59], 2H3L [60]; (D) 2H2B, 2H3M [60]; E1: 3DIW [44],
3GJ9 [46]; E2: 3DJ1, 3DIW [44], 3GJ9 [46], 2KG2 [114]; (F) 3L4F [47], 1Q3P [115]; (G) 3QGL [48]; (H) 2KPL [52], 2I04 [50]; (I) 3K1R [66]; (J) 2KBS [67]; (K) 3CYY [69]. Figures
were created with Pymol [113] (see suppl. data for the pymol session ﬁles).
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E5 of the C-terminal peptide of GIRK3 (Fig. 2G). Another interest-
ing example is that of the trimer of bPix bound to the SHANK1 PDZ.
The homotrimer is formed by the coiled-coil domain of bPix lead-
ing to three closely located C-termini all carrying the PBM of bPix
[47]. However, due to steric hindrance, only one of the three C-
termini is accessible for binding to SHANK1 PDZ [47]. Here, the
additional pocket formed by the b2–b3 loop, b2, and b3 strand
adopts a hemispheric shape and interacts with one side of the ring
of W5 from bPix (Fig. 2F). The other side seems to be covered from
solvent by residues from the coiled-coil domains. In that way, W5
may contribute to the stabilisation of the whole complex.
In most cases, this additional pocket is occupied by peptide
residues from position -5. However, it can sometimes be occupied
by residues at different positions, such as W4 for a phage dis-
play-derived peptide bound to Erbin PDZ (Fig. 2C) [59], W6 for
a phage display-derived peptide bound to PDZ1 of ZO1 (Fig. 2D)
[60], and Y7 for ErbB2 peptide bound to Erbin PDZ (Fig. 2C)
[61]. Together with observations that peptide residues at position
-4 can either contact domain residues from the b2 or b3 strand,
from a2 helix or from the b2–b3 loop (see table in Fig. 2), this
demonstrates to which extent peptides can adapt to PDZ do-
mains. A rigid deﬁnition of pairs of domain and peptide residues
as often considered in PDZ–peptide interaction predictors, would
not reﬂect this adaptability and is therefore likely to be an inap-
propriate model.
3.7. Alternative splicing of the b2–b3 loop can modulate the peptide
binding properties of PDZ domains
A very different example of inﬂuence of the b2–3 loop on pep-
tide binding is provided by PDZ2 of the tyrosine protein phospha-
tase hPTP1E (or its mouse homolog PTP-BL). This PDZ domain
represents one of the few PDZs subject to alternative splicing,
and to our knowledge is the only one that was studied in detail
(with in total 8 structures deposited in the PDB). The alternatively
spliced form (PDZ2as) exhibits an insertion of 5 residues (VLFDK)
at the start of the b2–b3 loop that abrogates binding to the C-ter-
minal peptide of APC and RIL (reversion-induced LIM protein)
[62–64] (Table 1). Two NMR structures of PDZ2as exist but the ﬁne
structural interpretation of how the insertion negatively inﬂuences
peptide binding remains a matter of debate as the two structures
considerably diverge from each other (Fig. S1) [63,64]. The alterna-
tive splicing event leads to replacement of the GG hinge region at
the beginning of the b2–b3 loop (a conserved feature in the PDZ
fold) by the more conformationally restricted VL sequence [64].
This appears to induce a displacement of the loop, which, together
with a global destabilisation of the domain, seems to be the main
cause for the observed inability of PDZ2 as to bind to C-terminal
peptides [64]. It will be interesting to see how alternative splicing
might modulate the binding behaviour of other PDZ domains and
whether these are used in vivo to regulate PDZ–peptide interac-
tions [65].
3.8. Upstream residues of a PDZ-bound peptide can interact with
residues that do not belong to the core of that PDZ domain
In most of the cases upstream peptide residues interacted with
residues of the core PDZ domain but there are also a few very inter-
esting instances where they interact with residues from PDZ exten-
sions or from other proteins. Atomic contacts could be observed by
NMR between residues (Ser, Leu, and Val) of the C-terminal exten-
sion of PDZ2 (PDZ1) of MAGI1 and R5 and T6 of a bound C-termi-
nal peptide derived from HPV16 E6 [52] (Fig. 2H). This signiﬁcantly
restricted the disordered conformation of the C-terminal extension
of PDZ2 in the presence of bound peptide [52]. Mutation of thethree residues SLV to either RKR or GGG resulted in threefold
and ﬁvefold reduced binding afﬁnity in comparison to the wild
type, respectively [52] (Table 1).
Harmonin and Sans are two proteins that are implicated in the
Usher syndrome. The N-domain, PDZ1, and a C-terminal extension
of PDZ1 of Harmonin form an integral domain that binds to a PBM
located at the C-terminus of Sans [66]. This interaction is further
stabilised by interaction between the SAM (sterile alpha motif) do-
main of Sans and PDZ1 of Harmonin leading to an extremely tight
complex (reviewed in detail by Wang et al. [33]) (Table 1). L5 in-
serts into a hydrophobic pocket formed by residues from the b2
and b3 strand, from the b2–b3 loop, and from the C-terminal
extension (Fig. 2I). Additionally, hydrogen bonds were observed
between Lys from the C-terminal extension and the backbone of
A6 [66]. The PDZ2 domain of Harmonin, complexed to the C-ter-
minal peptide of the cell adhesion protein Cadherin23, exhibits
an additional C-terminal a helix [67]. Interestingly, the C-terminal
tails of Cadherin23 and of Sans are very similar with identical res-
idues at p5, 4, 2, 1, 0. L-5 of Cadherin23 interacts with resi-
dues of the extension and the core PDZ domain in a similar way as
L-5 of Sans, although in the case of PDZ2 it is a hydrophobic patch
that is formed instead of the pocket reported for PDZ1 (Fig. 2J).
Comparing the structure of PDZ2 of Harmonin with the one from
PDZ3 of ZO1 revealed a very similar hydrophobic patch formed
from the additional C-terminal a helix of PDZ3 and residues from
the b2–b3 loop and the b2–b3 sheet. No difference in binding afﬁn-
ity could be observed to the C-terminal peptide of the gap junction
protein Connexin45 when the helical extension of PDZ3 of ZO1 was
removed [68]. Yet we speculate that an increase in afﬁnity might
have been observed for peptides possessing residues at upstream
peptide positions that would have been capable to interact with
this hydrophobic surface.
ZO1 and ZO2 PDZ2 were shown to exist as homodimers [69,70].
The complex of ZO1 PDZ2 bound to the PBM of Connexin43, re-
vealed that due to dimerization the extended peptide binding
pocket is altered. This has been reviewed more in detail by Wang
et al. [33]. The b5–a2 loop of the other PDZ is placed in front of
the end of the binding pocket forcing the peptide to make a bend
at position -5 that is occupied by a Pro in Cx43. D4 and R6 are in-
volved in several interactions with residues from the b5–a2 loop
(Fig. 2K, Table 1) [69].
Unfortunately, the Harmonin-Sans/Cadherin23 and ZO1-Cx43
complexes have neither been mutated nor compared to complexes
of Harmonin and ZO1 with PBMs of other known binding partners.
Such analyses would have helped to better understand the contri-
bution of observed interactions between residues from PBM and
PDZ extensions to complex formation. However, given the numer-
ous precise residue contacts observed, it is tempting to speculate
that these additional interactions between PBM and PDZ might in-
crease the speciﬁcity of the PDZ domains for their peptide targets.
3.9. General remarks
It clearly emerges that residues of PBM extensions inﬂuence the
afﬁnity of peptides to PDZ domains and some studies provide clear
evidence that this increases the speciﬁcity of PDZ–peptide interac-
tions. The b2–b3 loop contributes to an extended binding pocket.
Owing to the huge variability of this loop in length (up to 36 resi-
dues, PDZ of ARHGAP21, PDB ID: 2YUY [71]) and sequence compo-
sition, observed interactions between residues of the loop and of
the peptide were of impressive diversity. It seems rather impossi-
ble to derive any rule about how the b2–b3 loop and the peptide
extensions contribute to PDZ–peptide binding. Most likely, this
complex system of interactions is at the moment unpredictable.
Interestingly, the contribution of upstream peptide residues for
the binding to PDZ domains seems to be subject to regulation as
2654 K. Luck et al. / FEBS Letters 586 (2012) 2648–2661they were observed to overlap with phosphorylation sites. Re-
ported phosphorylation of upstream PBM residues led either to
an increase in binding afﬁnity (S8 of Cadherin bound to PDZ3 of
Par3 [57]) or to a decrease (Y-7 of ErbB2 bound to Erbin PDZ
[61], S-9 of Cx43 bound to PDZ2 of ZO1 [69]) [72] (Table 1). It ap-
pears that experimental studies on PDZ–peptide interaction speci-
ﬁcities should systematically include peptides of different length
(e.g. core PBMs and extended PBMs) to account for the role that up-
stream peptide residues play for PDZ binding.
In principle, extending the binding interface between PDZs and
peptides is likely to increase afﬁnity between both. However, none
of the cellular peptides that we have described above possessed an
optimal sequence for the entire binding site. This observation is re-
ﬂected by the fact that three artiﬁcial peptides (a phage display
peptide, mutated Kir2.3 peptide, mutated HPV16 E6 peptide) dis-
played much higher afﬁnity to PDZ domains than the identiﬁed
natural binding partners (Table 1). Noteworthy enough, a high
afﬁnity interaction is not necessarily speciﬁc, as one or both of
the interaction partners might bind many other proteins with sim-
ilarly high afﬁnity. Conversely, a low afﬁnity interaction can be
speciﬁc, if most other interactions engaged by the two partners
are of even lower afﬁnity. As mentioned in the introduction, SLiMs
seem too short to fully account for speciﬁc protein interactions. It
is tempting to speculate that the extended binding interfaces re-
viewed herein serve to provide a balanced mix of advantageous
and disadvantageous interface contacts, which guarantee the weak
yet speciﬁc interactions typically observed in cell signalling.4. Sequence context of PDZ domains
4.1. Deﬁning the core and boundaries of PDZ domains: theory and
practise
The canonical core PDZ fold is deﬁned by the arrangement of its
secondary structure elements, namely six b strands and two a heli-
ces (Fig. 1A). In theory, the boundaries of a PDZ domain are thus
deﬁned by the ﬁrst residue of the ﬁrst b strand and the last residue
of the last b strand of the canonical PDZ fold. The web servers
SMART [28] and Pfam [73], both based on Hidden Markov Models,
efﬁciently detect PDZ domains, including quite divergent instances
presenting structural rearrangements (such as the PDZ-like do-
mains from HtrA and EpsC (see below) [74,75]). However, these
programs have not been developed for accurately predicting the
boundaries of the core domain structures.
In practise, the boundaries of most experimental PDZ con-
structs that have been used for structural studies or interaction
assays, generally extend beyond the strict boundaries of the
core PDZ structure. Such extensions vary from a few residues
to longer stretches, which may be structured. Whereas Bhat-
tacharya et al. [76] and Wang et al. [33] proposed approaches
for predicting some secondary structure elements within PDZ
extensions, the conformation of extensions and their impact
on the solubility, stability and peptide binding properties of
PDZ constructs (see following paragraphs) remain largely
unpredictable.4.2. A PDZome-wide database of suggested PDZ construct boundaries
derived from structural information
The lack of a general rule for designing boundaries of PDZ do-
main constructs raises a practical issue concerning past and future
experimental studies aimed at producing and comparing the func-
tional properties of large numbers of PDZ domains. How can hun-
dreds of PDZ constructs be properly designed? One solution to thisproblem may be to take advantage of the impressive structural
data already available on PDZ domains. Indeed, successful struc-
ture determination probably represents the most relevant a poste-
riori quality proof for construct boundaries. Based on this principle,
we propose here a list of manually curated domain boundaries se-
quences for the 266 PDZs that constitute to our knowledge the hu-
man PDZome (Table S1). For each known PDZ domain, we
identiﬁed the three most similar PDZ domains for which structures
were available and applied a set of hierarchized criteria (see suppl.
material for protocol) to ﬁnally deﬁne the construct boundaries of
the considered PDZ domain.
Noteworthy enough, the structures of about 120 human PDZs
have been solved, and for most of the other human PDZs, the
structure of one or several very closely related orthologous PDZ
domains is available in the Protein Data Bank (PDB) (Fig. 1B).
Therefore, the majority of constructs proposed in our curated list
are either identical or highly similar to constructs for which a
structure has been solved. On average, the constructs proposed
in our list, including those of known structure, are 16 and 5 res-
idues longer at the N- and C-terminus, respectively, than the start
and end of the sequence predicted by SMART. In particular,
SMART-predicted boundaries consistently excluded the ﬁrst b
strand of PDZ domains. Therefore, the raw SMART output is not
sufﬁcient for domain boundary prediction. This database provides
a ﬁrst suggestion of boundaries for the cloning of PDZ constructs
from human or related proteomes. Of course, semi-empirical opti-
mization of construct solubility and/or stability may still remain
necessary in some cases [77].
4.3. PDZ extensions
The emerging roles of extensions of PDZ domains was ad-
dressed in a review by Wang et al. [33]. Here, we aim at comple-
menting this review by focussing on recently published studies
and by putting emphasis on the implications that extensions have
on peptide binding.
4.3.1. Extensions that inﬂuence the dynamics, stability and solubility of
PDZ domains
PDZ2 of NHERF1 (Na(+)/H(+) exchange regulatory cofactor 1)
and PDZ3 of DLG4 (disks large homolog 4) have helical C-terminal
extensions that were shown to be important for the stability and
dynamics of the PDZ domain, respectively [76,78]. In both cases,
removal of the extension did not alter the fold of the core PDZ
domain but led to signiﬁcantly decreased afﬁnity to C-terminal
peptides [76,78] (Table 2). Petit et al. [78] showed that a construct
of PDZ3 of DLG4 lacking the extension, displays more side chain
ﬂexibility leading to increased entropy that makes peptide bind-
ing energetically less favourable. Both studies were reviewed
more in detail by Wang et al. [33]. A recent molecular dynamics
study [49] suggested that the helical extension of PDZ3 of DLG4
establishes ionic contacts with core PDZ residues. These contacts
seemed to restrain the backbone ﬂexibility of the b2–b3 loop
and the carboxylate binding loop, thereby facilitating peptide
binding.
The PDZ2 (PDZ1) domain of MAGI1 was shown to have a struc-
tured N-terminal and an unstructured C-terminal extension [52].
The C-terminal extension seemed to be essential for obtaining sol-
uble and stable constructs. The N-terminal extension was shown to
shield from solvent a hydrophobic patch that comprised a cysteine
residue, thereby preventing the formation of soluble aggregates via
non-native intermolecular disulﬁde bonds [77,52]. Mutations in
the C-terminal (see previous section dealing with PBM extensions)
and N-terminal (unpublished data) extensions weakened the bind-
ing afﬁnity of PDZ2 to the HPV16 E6L/V peptide.
Fig. 3. Sequence alignment of the PDZ-SH3 linker of the human MAGUK family of proteins. Secondary structure elements on top of the alignment are indicated based on the
structure of the PDZ3-SH3-GK module from ZO1 (PDB ID: 3SHW [68]). An initial alignment was built with Mafft [116] and corrected by hand using Jalview [117]. The asterisk
indicates the phosphorylation site described for ZO1, which seems to be conserved for some members of the MAGUK family.
Table 2
Mutagenesis performed to study sequence context of PDZ domains. The table summarizes the mutational data obtained from studies that analysed the inﬂuence of extended PDZ
domains or multido-main constructs on peptide binding. If available, measured binding afﬁnities are indicated. SS-bridge = disulﬁde bridge.
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DLG4 has a phosphorylation site (Y397) located in the helical C-
terminal extension (hereafter called a3 helix) of PDZ3 [79]. Zhanget al. [80] studied the effect of this phosphorylation site on the
structure of the extended PDZ3 domain and on ligand binding.
Phosphorylated Y397 led to an equilibrium between a locally
2656 K. Luck et al. / FEBS Letters 586 (2012) 2648–2661unfolded and folded state of the a3 helix reﬂected by a fourfold de-
crease in afﬁnity of phosphorylated PDZ3 in comparison to the
unphosphorylated extended PDZ3 domain (Table 2).
DLG4 is a member of the membrane associated guanylate ki-
nase (MAGUK) family of proteins together with four other DLG pro-
teins, 3 ZO proteins, CASK (calcium/calmodulin-dependent serine
protein kinase), and 7 MPP (membrane protein, palmitoylated)
proteins [81]. All of these proteins share a common domain
arrangement consisting of a PDZ domain followed by an SH3 (Src
homology 3) and GK (guanylate kinase) domain (hereafter called
PSG module). In addition to DLG4, the PDZ domain of the PSG mod-
ule of ZO1 and DLG1 was also shown to possess an a3 helix. The a3
helix as well as the phosphorylation site seem to be conserved in
the ZO and DLG subfamily of proteins (except for DLG5) (Fig. 3).
Remarkably, the linker sequence between PDZ3 and SH3 of
DLG1-4 is much longer than for the other members of the MAG-
UK-family. Three phosphorylated serines are reported in the linker
region of DLG1-4 [82,83]. Furthermore, by using the ELM resource
[84], we predicted in this linker a very likely actin binding site (LI-
G_Actin_WH2_2). To our knowledge, DLG proteins have not yet
been demonstrated to bind to actin, yet they are already known
to be involved in the regulation of actin ﬁlaments [85]. Therefore,
it might be interesting to investigate the functional role of this ac-
tin binding site and its potential inﬂuence on peptide binding by
the neighbouring PDZ3 and SH3 domains. The linker sequence of
the MPP family is shorter than for the ZO and DLG proteins and
does not display any conserved features. Furthermore, the region
in MPP proteins that corresponds to the a3 helix observed in ZO
and DLG proteins, tends to be proline-rich (Fig. 3) and is therefore
unlikely to adopt a helical conformation.
In summary, this data suggests that a helical extension of the
PDZ of the PSG module is a property shared by DLG1-4 and all
three ZO proteins and that it might be used as a regulatory element
to control peptide binding to PDZ3 via phosphorylation and actin
binding.
4.3.3. PDZ extensions that modulate the conformation of the binding
pocket
The PDZ domain of Par6 (partitioning defective 6 homolog) has




Fig. 4. Sequence context of PDZ domains. (A) Short (yellow, sPDZ, PDB ID: 2I6V) and long
[75]. lPDZ has an additional N-terminal a helix (a1) that leads to different conformatio
lPDZ to a closed peptide binding pocket. (B) Comparison of two complexes between the
green) [107] and Cx45 (orange) [68]. The PDZ3 domains bound to JAM-A and Cx45 are sh
and brown. The additional C-terminal a helix of PDZ3 is labelled a3. R436 possesses d
position p1 (W in Cx45 and L in JAM-A). The ﬁgures were created with Pymol [113] (sactive binding) domain that adopts a b strand when bound by
Cdc42 (Cell division control protein 42 homolog) [86]. The associ-
ation of Cdc42 with the extended PDZ of Par6 leads to a 10-fold in-
crease in afﬁnity for C-terminal peptides bound by the PDZ [87]
(Table 2). Several studies have been published investigating the
mechanism and implications of the Cdc42-Par6 interaction that
are in detail reviewed in Wang et al. [33]. Very recently, Whitney
et al. [88] published structural details about how the signal result-
ing from Cdc42 binding to the CRIB domain is propagated to the
binding pocket of the PDZ, thereby altering PDZ–peptide binding.
By introducing a disulﬁde bridge between the otherwise very ﬂex-
ible CRIB domain and the core PDZ, they obtained a construct that
appeared to mimick the structure of the CRIB-PDZ module when
bound to Cdc42 and that was amenable for NMR studies. By com-
paring the structure of the disulﬁde-bridged mutant with a struc-
ture of the single PDZ and a structure from the Cdc42–Par6
complex, they revealed a switch in conformation of two residues
(Lys and Leu) in the b1–b2 loop that reshapes the binding pocket
upon Cdc42 binding and thereby facilitates peptide binding [88].
PDZ5 of INADL, a core component of the phototransduction path-
way, has a pair of cysteines located in the peptide binding pocket,
that is in reduced form in absence of light and forms a disulﬁde
bridge upon light exposure [89]. C-terminal peptides were shown
to bind signiﬁcantlyweaker to the oxidized formof PDZ5 in compar-
ison to its reduced form [7] (Table 2). Interestingly, whereas the iso-
lated PDZ5was stable in its oxidized form, the reduced formof PDZ5
was prevailing within a PDZ4-PDZ5 tandem construct [7]. The crys-
tal structure of PDZ4 and PDZ5 shows that they form a tightmodule
that is stabilised by a C-terminal extension of PDZ5 that binds to the
surface of PDZ4, and a N-terminal extension of PDZ4 that folds back
onto PDZ4 [7]. Liu et al. [7] further provide interesting data that sug-
gests that the C-terminal extension of PDZ5 is involved in a regula-
tory switch that changes the redox state of PDZ5 in the cell. Rapid
light-induced acidiﬁcation happens during signal transduction in
the microvilli of eyes. This can lead to a local signiﬁcant decrease
of the pH that would be enough to protonate a histidine residue of
PDZ4 leading to the disruption of its hydrogen bond with a threo-
nine residue of the C-terminal extension. Consequently, the interac-
tion between the C-terminal extension and PDZ4 is disturbed












(green, lPDZ, PDB ID: 2I4S) version of the PDZ domain of the bacterial EpsC protein
ns of a0 and a2. Two Phe are differently positioned (indicated in sticks) that lead in
PDZ3-SH3-GK module of ZO1 and C-terminal peptides derived from JAM-A (forest-
own in light-green and yellow, respectively, the corresponding SH3 domains in cyan
ifferent conformations in the two complexes due to different residues at peptide
ee suppl. data for the pymol session ﬁles).
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the formation of the disulﬁde bond. Possibly, the redox switch is
used to initiate the dissociation, from INADL, of proteins such as
the Ca2+-permeable channel protein TRP and the phospholipase
PLCb. These dissociation events would serve to mediate signalling
in photoreceptors upon light exposure.
Several bacterial proteins such as EpsC, a component of the type
2 secretion system of V. cholerae, contain PDZ-like domains that
display a circularly permuted topology as compared to canonical
PDZ folds [10,75]. In addition to this structural particularity, the
carboxylate binding loop of the PDZ-like domain of EpsC is re-
placed by a small helical structure (hereafter called a0) [75] (see
Fig. 4A). Both, the isolated PDZ-like core domain (sPDZ) and a long-
er construct (lPDZ) were crystallized. The lPDZ construct revealed
an additional N-terminal a helix, which establishes many hydro-
phobic interactions with residues of the PDZ-like core structure
[75]. The structures of sPDZ and lPDZ vary in the positioning of
the a 2 helix (average difference of Ca atoms is about 3), which
is further apart from b2 in sPDZ, thereby opening a deep and nar-
row hydrophobic groove formed between b2, a0, and a2 [75] (the
numbering of secondary structure elements corresponds to the
canonical topology of PDZs). The two structures also display signif-
icant differences in the positioning of a0. These two restructuring
events cause a change in conformation of two Phe residues (one
from a0, one from a2) that close the hydrophobic groove in lPDZ
(Fig. 4A). It will be very interesting to investigate the binding prop-
erties of this very special PDZ-like domain that might have evolved
to bind different molecules as has been suggested by the authors
[75]. These three latter examples illustrate very different mecha-
nisms by which peptide binding to PDZ or PDZ-like domains can
be directly modulated via extensions that inﬂuence the conforma-
tion of the peptide binding pocket. Other mechanisms of peptide
binding pocket modulation via extensions may exist for other
PDZ domains, which would be interesting to ﬁnd and investigate.
4.3.4. PDZ extensions that inﬂuence the folding of the PDZ domain
The assembly of PDZ4 and PDZ5 of INADL into a tight module,
which was described in the previous section, also represents an
example where the N- and C-terminal extensions were essential
for obtaining soluble and folded constructs [7]. Very similar obser-
vations were obtained for PDZ4 and PDZ5 of GRIP1 (Glutamate
receptor-interacting protein 1). Removal of the N-terminal exten-
sion of PDZ4 of GRIP1 led to spontaneous unfolding of the PDZ45
tandem [90] and prevented peptide binding [91] (more in detail re-
viewed elsewhere [5,33]). Together with the N-terminal extension
of PDZ1 of Harmonin [66], these are also three examples where
extensions of PDZ domains contribute to the construction of mul-
tidomain arrangements that ultimately alter the peptide binding
behaviours of the PDZ domains being involved [33].
4.3.5. Non-exhaustive collection of structured and unstructured
extensions that would deserve further investigation
- PDZ1 of INADL (PDB ID: 2DB5, NMR, [92]) has an additional N-
terminal a helix that folds into a hole formed between the b2–
b3 sheet and the b1–b5 sheet, and that is parallel to the b4
strand.
- PDZ1 of MPDZ (PDB ID: 2O2T, Xray, [93]) has an additional N-
terminal and C-terminal a helix that both, contact the PDZ.
The N-terminal helix is very similar to the one mentioned for
PDZ1 of INADL.
- PDZ3 of Harmonin (PDB ID: 1V6B, NMR, [94]) has an additional
N- terminal a helix that does not fold back on the PDZ core but
establishes hydrophobic contacts with Val at the beginning of
the b1 strand and Phe of the partially structured N-terminal
extension that precedes the N-terminal a helix.- The PDZ of MPP5 (PDB ID: 1VA8, NMR, [95]) has a small b hair-
pin that is formed at the N-terminus of the PDZ.
- PDZ7 of INADL (PDB ID: 2DAZ, NMR, [96]) has an N-terminal
and C-terminal a helix that both, fold back on the PDZ core.
The N-terminal helix is in slightly different orientation in com-
parison to PDZ1 of INAD and MPDZ. Here, the helix rather aligns
to the b1- b5 sheet.
- PDZ2 of Harmonin (see section PBM extensions, PDB ID: 2KBS,
NMR, [67]).
- PDZ2 (PDZ1) of MAGI2 (PDB ID: 1UEQ, NMR, [97]) has struc-
tured N-and C-terminal extensions that fold back onto the
PDZ core and that are similar to those observed for PDZ2 of
MAGI1 (see sections PBM extensions and PDZ extensions).
- The PDZ of PLCO (PDB ID: 1UJD, NMR, [98]) has a structured C-
terminal extension that folds back onto the PDZ core.
4.3.6. General remarks
We have seen that PDZ extensions can inﬂuence the binding
afﬁnity of peptides to PDZ domains via a wide range of possibilities.
Yet, do extensions also affect the binding speciﬁcity of peptides to
PDZs? PDZ extensions that either directly interact with peptide
residues (see section dealing with PBM extensions), as well as
extensions that directly or indirectly alter the conformation of
the peptide binding pocket, are very likely to increase the binding
speciﬁcities of the corresponding PDZs. By contrast, PDZ extensions
affecting the general fold, stability, dynamics of the PDZ, or partic-
ipating in its general regulation, may more often impact indiffer-
ently the general binding behaviour of the PDZ to any of its
targets, thereby not increasing binding speciﬁcity. Overall, these
uncertainties strongly call for studies that will further focus on
the impact of PDZ extensions on peptide binding speciﬁcities.
4.4. Inﬂuence of neighbouring domains on peptide binding to a PDZ
4.4.1. PDZ tandems
It is a well known property of PDZ domains that they often oc-
cur in multiple copies within one protein sequence. More and more
evidence accumulates that neighbouring PDZ domains inﬂuence
each other’s structure and binding behaviour, especially those that
are connected by very short linkers (reviewed in [5]). As structural
data of such tandem PDZ domains indicate, they can be tightly
packed and form one unit. The term supramodule was introduced
to account for this property [5]. Two examples of such supramod-
ules (PDZ45 of INADL and of GRIP1) were already mentioned in the
previous section.
The PDZ12 tandem of DLG4 (PSD95) has been the subject of sev-
eral publications. Based on the observation that PDZ1 and PDZ2 of
DLG4 can bind to the same set of C-terminal peptides, it has been
suggested that the two PDZs can bind simultaneously to the C-ter-
mini of homo- or heteromeric channel proteins of the postsynaptic
density [99]. It has been shown that such synergistic binding leads
to an increase in afﬁnity and speciﬁcity as those ligands occurring
in dimeric form are favoured as compared to monomeric ligands
[99] (see review of Feng et al. [5] for more details). This property
was successfully used to develop biomimetic divalent ligands that
were much more efﬁcient than monovalent ligands in disrupting
the binding of DLG4 to its interaction partners [100,101]. Such a
binding model would be favoured by an arrangement of PDZ1
and PDZ2 where the peptide binding pockets point to the same
direction. Five very recent studies concentrated on the domain ori-
entation of PDZ12 of DLG4 and revealed interesting ﬁndings. Using
various techniques (NMR, crystallography, molecular dynamics
simulations, single molecule FRET), very different conformations
of the PDZ12 tandem were suggested ranging from a parallel align-
ment of the binding pockets to an antiparallel arrangement
[99,100,102]. In addition, Wang et al. [103] provided data that
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orientations in the ligand-free state, encounters a dramatic in-
crease in ﬂexibility when bound to a C-terminal peptide. Equiva-
lent observations have been obtained for PDZ12 of DLG4 when
bound to a divalent ligand [101]. Remarkably, McCann et al.
[102] could further demonstrate that domain orientation and ﬂex-
ibility of the single PDZ tandem was comparable to those obtained
in full length DLG4. It seems that, depending on the cellular con-
text, parallel alignment of the binding pockets of PDZ12, which
would favour multivalent ligand binding, is as likely as antiparallel
alignment, which would instead enable recruitment of cytosolic
proteins to membrane receptors [102]. More studies are needed
to investigate this model. The fact that very different conclusions
can be drawn from studies using different biophysical methods
may indicate that methodologies remain of limited accuracy for
the study of large and dynamic systems such as tandem PDZs.
4.4.2. Autoinhibition of PDZ domains
NHERF1 and X11 (amyloid beta A4 precursor protein-binding
family Amember 1, reviewed in [5]) have PDZ domains whose pep-
tide binding is regulated via an autoinhibitory mechanism that in-
volves PBMs at their own C-termini [104,105]. In an interesting
NMR study, Bhattacharya et al. [76] investigated the molecular de-
tails of this autoinhibition for PDZ2 of NHERF1. NHERF1 has two
PDZ domains and a C-terminal EB (Ezrin binding) domain that
binds to Ezrin (involved in linking cytoskeletal structures to the
plasma membrane) and that overlaps with a PBM at the C-termi-
nus of NHERF1. Binding of Ezrin to the EB domain increases afﬁnity
of PDZ2 to the C-terminal peptide of CFTR (Cystic ﬁbrosis trans-
membrane conductance regulator) by 24-fold [106,76]. NMR data
indicates that the PBM at the C-terminus of NHERF1 can very
weakly and transiently bind into the peptide binding pocket of
PDZ2. When Ezrin binds to the EB domain, the whole EB domain
including its PBM adopts a helical conformation and dissociates
from PDZ2, making the peptide binding pocket fully accessible
for binding to PBMs of other proteins [76].
4.4.3. Inﬂuence on PDZ–peptide binding from neighbouring domains of
different type
In 2011, two articles were published within less than a month,
reporting the crystal structure of the PDZ3-SH3-GK (PSG) module
of ZO1 com-plexed to C-terminal peptides derived from either
the cell adhesion proteins JAM-A [107] or the gap junction protein
Connexin45 (Cx45) [68]. Both studies agree on the overall ex-
tended shape of the PSG module (PDZ3 does not contact the GK do-
main). An additional C-terminal a helix (hereafter called a3) of
PDZ3 is located in the linker region between the PDZ3 and SH3 do-
main. Residues of the a2 and a3 helix as well as of the b2–b3 loop
of PDZ3 interact with residues from the PDZ-SH3 linker and the
SH3 domain. In both crystals, the peptides only partially insert into
the binding pocket of PDZ3. The backbone of the peptides exhibit a
shift towards the b2 strand, probably forced to this different
conformation by the b2–b3 loop of the SH3 domain that is located
in front of the peptide binding pocket (Fig. 4B) [107,68]. In both
structures the PDZ3-SH3 linker inserts between the b2–b3 loop
and the SH3 domain, making the loop inaccessible for interaction
with peptide residues. Interestingly, no binding could be observed
between JAM-A and the single PDZ3 domain [107] and Cx45
exhibited a 9-fold reduced binding afﬁnity to the single PDZ3 in
comparison to the afﬁnity obtained for the PSG module [68]. Sim-
ilar observations for CRIPT and Neuroligin peptides were indepen-
dently obtained for the equivalent PSG module of DLG (Disks large)
from D. melanogaster [108] (Table 2). This difference in afﬁnity
might mostly be due to a hydrophobic residue located at p-2 of
the peptides (this residue is a Phe in JAM-A and a Val in Cx45) that
inserts into a hydrophobic pocket formed by residues from boththe a2 helix of PDZ3 and the b2–b3 loop of the SH3 domain of
ZO1 [107,68].
The side chains of PDZ3 exhibit almost identical conformations
in the two complexes except of R436 from the b2 strand. The ali-
phatic part of the side chain of R436 establishes hydrophobic con-
tacts with Leu and Trp at p-1 in JAM-A and Cx45, respectively.
However, in the PSG-Cx45 complex, the side chain of W1 of
Cx45, being bulkier than L1 of JAM-A, displaces the side chain of
R436 of PSG, which consequently occupies space that is used by
S3 in the PSG-JAM-A complex (Fig. 4B). This in turn displaces
S3 and more upstream residues of the Cx45 peptide further away
from the PDZ domain as compared to the equivalent residues from
the JAM-A peptide. This may be the main reason for the differences
in backbone conformation observed for the peptides in the two
crystals (Fig. 4B). Based on these observations, one would expect
that the JAM-A peptide binds stronger to the PSG module than
the Cx45 peptide. Surprisingly, the contrary is the case (Table 2).
In both peptides, residues at p3 and p4 are very similar being
either serine or threonine, while residues further upstream were
not observed to signiﬁcantly contribute to the binding. Hence,
the difference in afﬁnity can only be explained from sequence dif-
ferences at the last three peptide positions being either VWI for
Cx45 or FLV for JAM-A. It seems likely that residues W1 (based
on previous observations [109]) and Ile at p0 (preference of Leu
or Ile over Val at p0 [19]) are the main contributors to the higher
afﬁnity of Cx45 to PDZ3. Based on these observations, we speculate
that despite of binding with less afﬁnity, JAM-A seems to bind with
higher speciﬁcity to the PSG module than Cx45.
In summary, the structures of these two complexes revealed
very interesting ﬁndings. To our knowledge, they are the ﬁrst to
provide atomic details for the direct inﬂuence that non-PDZ do-
mains can have on the peptide binding of their PDZ neighbours.
They also show that, whenever possible, investigations of small
protein fragments such as single PDZs should be complemented
by and compared to investigations of larger protein constructs
(comprising multiple domains) or even full length proteins. They
also serve as a nice example that shows how peptide residues
can inﬂuence each other’s binding to the PDZ domain. Such ’’coop-
erative’’ effects are excluded frommost current PDZ–peptide inter-
action prediction models, which for complexity reasons assume
independence of the peptide residues.
4.5. Inﬂuence on PDZ–peptide binding from distal domains
A fourth type of sequence context has not been discussed in this
review, namely regions in protein sequences that are not in the
neighbourhood of PDZs but still inﬂuence their peptide binding
behaviour. We are convinced that numerous such examples exist,
but our current knowledge on this subject is very limited due to
a current lack of biophysical methods that allow studying larger
protein fragments or even full length proteins at the molecular le-
vel. The works of McCann et al. [102], who used single molecule
FRET to study the tandem PDZ12 in full length DLG4 as well as
of Pan et al. [68] and Nomme et al. [107] who published the
structure of the PSG module of ZO1, are promising steps towards
bridging this gap.5. Concluding remarks
This review has been focussed on the inﬂuence of sequence con-
text on PDZ–peptide interactions given the vast amount of data
available for the PDZ domain family. Other types of globular do-
main-linear motif interactions are much less studied and our
knowledge on sequence context in these systems is sparse. How-
ever, we think that it is very likely that sequence context will have
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been demonstrated for the PDZ domain family. A few studies
underpin this speculation (WW domain family [110], SH3 domain
family [111]).
To which extent does sequence context inﬂuence speciﬁcity of
PDZ–PBM interactions? An interaction between two proteins is
speciﬁc when their mutual binding afﬁnity is signiﬁcantly higher
than the afﬁnities of their interactions with most other proteins.
Therefore, in principle the speciﬁcity of a given PDZ–PBM interac-
tion can only be assayed by comparing its binding afﬁnity to the
binding afﬁnities of this particular PDZ domain towards a variety
of other PBMs, and/or to the binding afﬁnities of this particular
PBM towards a variety of other PDZ domains. Most of the studies
discussed here or elsewhere [5,33] show that sequence context
inﬂuences binding afﬁnity, yet they did not perform the compara-
tive studies to address interaction speciﬁcity. There is a need for
more studies including different interaction partners and protein
sequences of various lengths [26] to better understand how se-
quence context inﬂuences speciﬁcity of domain–SLiM interactions
in cell signalling processes.
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